跳至主要内容
临床试验/ISRCTN15371662
ISRCTN15371662
已完成
未知

Effects of high-intensity versus low-intensity praziquantel treatment on HIV disease progression and immunological responses among HIV and Schistosoma mansoni co-infected patients

Medical Research Council0 个研究点目标入组 363 人2017年2月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
HIV, schistosomiasis
发起方
Medical Research Council
入组人数
363
状态
已完成
最后更新
6年前

概览

简要总结

2019 results in https://pubmed.ncbi.nlm.nih.gov/30498791 (added 30/01/2020)

注册库
who.int
开始日期
2017年2月1日
结束日期
2015年12月31日
最后更新
6年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • 1\. ART\-naïve HIV\-positive men and women with evidence of co\-infection with S. mansoni
  • 2\. Aged 18 years or over
  • 3\. Not eligible for ART (CD4 count more than 350 cells/mm3 or not in WHO Stage IV and advanced stage III)
  • 4\. Willing to provide a stool sample for testing S. mansoni and other worms and accept treatment with praziquantel and albendazole
  • 5\. Willing to provide blood for viral loads, CD4 count and other blood tests
  • 6\. Able and willing to provide informed consent (literacy is not required)
  • 7\. Willing to undergo HIV testing, counseling and receive HIV test results
  • 8\. Available for follow\-up for study duration
  • 9\. Able and willing to provide adequate locator information for tracking purposes, and willing to be contacted by the study staff

排除标准

  • 1\. Pregnancy or planning to be pregnant during study period
  • 2\. Has taken praziquantel in the preceding 3 months
  • 3\. Symptomatic helminth infection (haemoglobin less than 8 g/dl, bloody diarrhea, clinically apparent liver disease)
  • 4\. Symptomatic complications of S.mansoni (vomiting blood, hepatosplenomegaly)
  • 5\. S. mansoni egg count more than 2000/g of stool as evidence points a high egg burden (\>2000 eggs/g) highly associated with periportal fibrosis

结局指标

主要结局

未指定

相似试验